Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia
· Delayed Price · Currency is SAR 129.60
+0.60 (0.47%)
Apr 28, 2025, 2:45 PM AST
TADAWUL:4016 Revenue
In the year 2024, Middle East Pharmaceutical Industries Company had annual revenue of 394.00M SAR with 16.42% growth. Middle East Pharmaceutical Industries Company had revenue of 135.99M in the quarter ending December 31, 2024, with 5.28% growth.
Revenue
394.00M
Revenue Growth
+16.42%
P/S Ratio
6.55
Revenue / Employee
623.42K
Employees
632
Market Cap
2.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 394.00M | 55.56M | 16.42% |
| Dec 31, 2023 | 338.44M | 35.78M | 11.82% |
| Dec 31, 2022 | 302.66M | 15.44M | 5.38% |
| Dec 31, 2021 | 287.22M | -14.44M | -4.79% |
| Dec 31, 2020 | 301.66M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Sulaiman Al Habib Medical Services Group Company | 11.20B |
| Nahdi Medical Company | 9.45B |
| Mouwasat Medical Services Company | 2.88B |
| Dallah Healthcare Company | 3.21B |
| Dr. Soliman Abdel Kader Fakeeh Hospital Company | 2.79B |
| Jamjoom Pharmaceuticals Factory Company | 1.32B |
| Almoosa Health Company | 1.20B |
| Al-Dawaa Medical Services Company | 6.45B |